These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16728441)

  • 1. Why are doctors still prescribing neuroleptics?
    Charlton BG
    QJM; 2006 Jun; 99(6):417-20. PubMed ID: 16728441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. If 'atypical' neuroleptics did not exist, it wouldn't be necessary to invent them: perverse incentives in drug development, research, marketing and clinical practice.
    Charlton BG
    Med Hypotheses; 2005; 65(6):1005-9. PubMed ID: 16182461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmaco-therapeutic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit].
    Armand-Branger S; Poisson N; Gaudoneix-Taïeb M; Ramos O
    Encephale; 2009 Sep; 35(4):370-6. PubMed ID: 19748374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new study of secondary effects in prescribing practices of neuroleptics].
    Lachaux B; Sechter D; Morasz L; Adouard D
    Encephale; 1997 Apr; 23 Spec No 2():25-34. PubMed ID: 9273304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective response to neuroleptics: the effect of a questionnaire about neuroleptic side effects.
    Taira M; Hashimoto T; Takamatsu T; Maeda K
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1139-42. PubMed ID: 16765499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroleptics in the newspaper. A mass media analysis].
    Hoffmann-Richter U; Wick F; Alder B; Finzen A
    Psychiatr Prax; 1999 Jul; 26(4):175-80. PubMed ID: 10457969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
    World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Swedish company doctors' attitudes to benzodiazepines and neuroleptics used as minor tranquillizers.
    Sällström G; Maasing R
    Pharmatherapeutica; 1980; 2(6):380-6. PubMed ID: 6107934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sertindole: new drug. Another "atypical" neuroleptic; QT prolongation.
    Prescrire Int; 2007 Apr; 16(88):59-62. PubMed ID: 17458045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical classification of neuroleptics. Critical study and current prospects].
    Kapsambelis V; Gekiere C; Ginestet D
    Encephale; 1990; 16(2):63-70. PubMed ID: 1972056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poison or cure: meanings of medication in schizophrenia.
    Rosenfield PJ
    J Am Acad Psychoanal Dyn Psychiatry; 2007; 35(2):189-201. PubMed ID: 17650972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Position of the pharmacologist. From neuroleptics to non-neuroleptic antipsychotics].
    Costentin J
    Encephale; 2009 Jan; Suppl 3():S119-22. PubMed ID: 19268181
    [No Abstract]   [Full Text] [Related]  

  • 15. Delirium associated with lithium-quetiapine combination.
    Miodownik C; Alkatnany A; Frolova K; Lerner V
    Clin Neuropharmacol; 2008; 31(3):176-9. PubMed ID: 18520985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic safety and efficacy concerns.
    Meyer JM
    J Clin Psychiatry; 2007; 68 Suppl 14():20-6. PubMed ID: 18284274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptics reconsidered.
    Daniels A
    QJM; 2006 Jun; 99(6):421-3. PubMed ID: 16728442
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
    Nothdurfter C; Eser D; Schüle C; Zwanzger P; Marcuse A; Noack I; Möller HJ; Rupprecht R; Baghai TC
    World J Biol Psychiatry; 2006; 7(3):162-70. PubMed ID: 16861142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
    Tamrakar SM; Nepal MK; Koirala NR; Sharma VD; Gurung CK; Adhikari SR
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):152-60. PubMed ID: 18603890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.
    Szulc A; Galińska B; Tarasów E; Kubas B; Dzienis W; Konarzewska B; Poplawska R; Tomczak AA; Czernikiewicz A; Walecki J
    Med Sci Monit; 2007 May; 13 Suppl 1():17-22. PubMed ID: 17507880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.